Certainly worth a try: if there are no extraneous factors that holders are unaware of: AIDS hasn't been cured ... no nasty surprises re results detail no bad feedback from prospective partners,
then that could only mean recent share-price decline can be attributed solely to the understated tone of the last announcement.
In which case a bit of shareholder massage wouldn't be a bad idea !
However ...
Avexa directors, to give them their due, have never really been in the shareholder-masseuse game,
and ...
I haven't had a response to a recent email I sent them asking that they spell out their 'trading-halt' vs 'price-sensitive' announcement policy, which I thought was a pretty reasonable question for a shareholder to ask.
So by all means, let's make our feelings known, but we mightn't get a response (unless we make ourselves really annoying).
P.
AVX Price at posting:
11.0¢ Sentiment: LT Buy Disclosure: Held